Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Claudin 18.2 Targeting: A Pan-Cancer Perspective.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 18, 2026
High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma.
Journal: Melanoma research
Published: February 04, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 08, 2026
Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads.
Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads.
Journal: Med (New York, N.Y.)
Published: November 11, 2025
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic Exposure.
Journal: Journal of clinical pharmacology
Published: August 29, 2025
Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies.
Journal: Seminars in cancer biology
Published: August 14, 2025
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.
Journal: Molecular cancer therapeutics
Published: July 21, 2025
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.
Journal: Molecular cancer therapeutics
Published: July 21, 2025
Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infants.
Journal: The Journal of antimicrobial chemotherapy
Published: May 20, 2025
B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades.
Journal: ImmunoTargets and therapy
Published: April 30, 2025
Gene- and immune-targeted therapy combinations using dual-matched biomarkers for patient selection.
Journal: NPJ precision oncology
Published: March 28, 2025
Nectin-4 expression patterns and therapeutics in oncology.
Journal: Cancer letters
Published: March 02, 2025
Last Updated: 09/26/2026